期刊文献+

HPLC法测定盐酸鲁拉西酮片中有效成分的含量 被引量:1

Determination of Lurasidione Hydochloride Tables by HPLC
下载PDF
导出
摘要 采用DIKMA Diamonsil C18柱色谱柱,以V(1%三乙胺溶液(磷酸调节至p H 3.5))∶V(乙腈)=65∶35为流动相,流速1.0 m L/min,柱温35℃,进样量10μL,检测波长为230 nm,建立了HPLC测定盐酸鲁拉西酮片中盐酸鲁拉西酮含量的方法。该方法对于盐酸鲁拉西酮检测浓度在0.15~0.45 mg/m L范围内线性关系良好(r=0.999 5),平均回收率为99.51%(RSD=0.59%)。此方法简便、结果准确,可用于盐酸鲁拉西酮片中有效成分的含量测定。 To establish HPLC method to determine the content of lurasidione hydrochloride tables. DIKMA Diamonsil C18( 150 mm × 4. 6 mm,5 μm) as analysis column and 1% triethylamine buffer solution( p H 3. 5)-acetonitrile( 65∶ 35) as mobile phase. The flow rate was 1. 0 m L / min and the detection wavelength was 230 nm,the column temperature was 35 ℃ and the injection volume was 10 μL. The calibration curve was linear in the range of 0. 15 ~ 0. 45 mg / m L for lurasidione hydrochloride( r =0. 999 5). The average recovery was 99. 51%( RSD = 0. 59%). The method appeared to be simple,quick and specific.
出处 《化学试剂》 CAS 北大核心 2015年第11期1015-1017,共3页 Chemical Reagents
关键词 盐酸鲁拉西酮片 高效液相色谱法 含量测定 lurasidone hydrochloride tables HPLC content determination
  • 相关文献

参考文献8

二级参考文献39

  • 1CAPUANO B, CROSBY IT, LLOYD EJ. Schizophrenia: genesis, receptorology and current herapeutics[ J]. Gurr Med Chem, 2002,9(5) :521 -548.
  • 2Lurasidone [ EB/OL]. [ 2011 - 01 - 17 ]. http://www.accessdata. fda. gov/drugsatfda docs/label/2010/200603s0011b1.pdf.
  • 3MEYER JM, LOEBEL AD, SCHWEIZER E. Lurasidone: a new drug in development for schizophrenia [ J ]. Expert Opin Investig Drugs, 2009,18 ( 11 ) : 1715 - 1726.
  • 4HEDLUND PB, SUTCLIFFE JG. Functional, molecular and pharmacological advances in 5-HT7 receptor research[ J]. Trends Pharmacol Sci, 2004,25 ( 9 ) :481 - 486.
  • 5Lurasidone clinical pharmacology biopharmaceutics review(s) [ EB/OL ]. [ 2011 - 01 - 17 ]. http ://www. aeeessdata, fda, gov/ drugsaffda_docs/nda/2010/200603 Orig1s000ClinPharmR. pdf.
  • 6ISHIYAMA T, TOKUDA K, ISHIBASHI T, et al. Lurasidone (SM-13496) , a novel atypical antipsychotic drug, reversesMK- 801-induced impairment of learning and memory in the rat passive-avoidance test[ J]. Eur .[ Pharmacol, 2007,572 ( N2 - 3 ) : 160 - 170.
  • 7NAKAMURA M, OGASA M, GUARINO J,et al. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebocontrolled trial[J].J Clin Psychiotry, 2009,70(6) :829 -836.
  • 8CITROME L. Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic [ J ]. Clin Schizophr Relat Psychoses, 2011,4(4) :251 -257.
  • 9CITROME L. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic[ J]. Int J Clin Prac, 2011,65(2) :188 -210.
  • 10舒良.精神分裂症防治指南[M].北京:北京大学医学出版社,2009:3.

共引文献25

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部